203 related articles for article (PubMed ID: 14666383)
1. Challenging cases in thyroid cancer: a multidisciplinary approach.
Tuttle M; Robbins R; Larson SM; Strauss HW
Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):605-12. PubMed ID: 14666383
[TBL] [Abstract][Full Text] [Related]
2. [Differentiated thyroid cancer].
Tiedje V; Schmid KW; Weber F; Bockisch A; Führer D
Internist (Berl); 2015 Feb; 56(2):153-66; quiz 167-8. PubMed ID: 25627410
[TBL] [Abstract][Full Text] [Related]
3. [Outcome in cervical recurrences of papillary or follicular thyroid cancer].
Mirallié E; Hamy A; Floch I; Sagan C; Paineau J; Murat A; Le Néel JC; Visset J
Ann Chir; 1999; 53(7):577-82. PubMed ID: 10520496
[TBL] [Abstract][Full Text] [Related]
4. Thyroid cancer: an overview.
Haq M; Harmer C
Nucl Med Commun; 2004 Sep; 25(9):861-7. PubMed ID: 15319589
[No Abstract] [Full Text] [Related]
5. Radioactive iodine therapy in poorly differentiated thyroid cancer.
Tuttle RM; Grewal RK; Larson SM
Nat Clin Pract Oncol; 2007 Nov; 4(11):665-8. PubMed ID: 17965644
[TBL] [Abstract][Full Text] [Related]
6. Use of imaging tests after primary treatment of thyroid cancer in the United States: population based retrospective cohort study evaluating death and recurrence.
Banerjee M; Wiebel JL; Guo C; Gay B; Haymart MR
BMJ; 2016 Jul; 354():i3839. PubMed ID: 27443325
[TBL] [Abstract][Full Text] [Related]
7. Recurrent follicular carcinoma-oxyphilic cell type (Hürthle cell carcinoma) of the thyroid, imaging with iodine-131 and technetium-99m tetrofosmin before and after radiotherapy.
Bomanji JB; Gacinovic S; Gaze MN; Costa DC; Ell PJ
Br J Radiol; 1998 Jan; 71(841):87-9. PubMed ID: 9534706
[TBL] [Abstract][Full Text] [Related]
8. Thyroglobulin and low-dose iodine-131 and technetium-99m-tetrofosmin whole-body scintigraphy in differentiated thyroid carcinoma.
Gallowitsch HJ; Mikosch P; Kresnik E; Unterweger O; Gomez I; Lind P
J Nucl Med; 1998 May; 39(5):870-5. PubMed ID: 9591591
[TBL] [Abstract][Full Text] [Related]
9. Nuclear imaging in the management of thyroid carcinoma.
Cavalieri RR
Thyroid; 1996 Oct; 6(5):485-92. PubMed ID: 8936676
[TBL] [Abstract][Full Text] [Related]
10. Is empiric 131I therapy justified for patients with positive thyroglobulin and negative 131I whole-body scanning results?
Ma C; Xie J; Kuang A
J Nucl Med; 2005 Jul; 46(7):1164-70. PubMed ID: 16000286
[TBL] [Abstract][Full Text] [Related]
11. Recurrent thyroid cancer. Role of surgery versus radioactive iodine (I131).
Coburn M; Teates D; Wanebo HJ
Ann Surg; 1994 Jun; 219(6):587-93; discussion 593-5. PubMed ID: 8203968
[TBL] [Abstract][Full Text] [Related]
12. Treatment of local and regional recurrences of differentiated thyroid cancer by radio-guided surgery with iodine-131.
Salvatori M; Ardito G; Pelizzo MR; Mariani G; Gross M; Al-Nahhas A; Rubello D
Nucl Med Rev Cent East Eur; 2006; 9(2):119-24. PubMed ID: 17304474
[TBL] [Abstract][Full Text] [Related]
13. Current issues in the management of differentiated thyroid cancer.
Mallick UK; Charalambous H
Nucl Med Commun; 2004 Sep; 25(9):873-81. PubMed ID: 15319591
[No Abstract] [Full Text] [Related]
14. Relationship between expression of the sodium/iodide symporter and 131I uptake in recurrent lesions of differentiated thyroid carcinoma.
Min JJ; Chung JK; Lee YJ; Jeong JM; Lee DS; Jang JJ; Lee MC; Cho BY
Eur J Nucl Med; 2001 May; 28(5):639-45. PubMed ID: 11383871
[TBL] [Abstract][Full Text] [Related]
15. False-positive uptake of I-131 in a laryngocele mimicking thyroid remnant after thyroidectomy for papillary thyroid carcinoma.
Schmidt M; Dietlein M; Schröder U; Schicha H
Clin Nucl Med; 2006 Nov; 31(11):716-7. PubMed ID: 17053394
[TBL] [Abstract][Full Text] [Related]
16. Radioiodine treatment in differentiated thyroid carcinomas. Treatment of first local recurrences and of bone and lung metastases.
Charbord P; L'Heritier C; Cukersztein W; Lumbroso J; Tubiana M
Ann Radiol (Paris); 1977; 20(8):783-6. PubMed ID: 610550
[No Abstract] [Full Text] [Related]
17. [Principles of radionuclide methods of diagnosing and treating primary thyroid cancer and its metastases].
Purizhanskiĭ II; Lushina LI; Lyzhina VD; Lisenkov PI
Med Radiol (Mosk); 1982 Oct; 27(10):61-6. PubMed ID: 7176859
[No Abstract] [Full Text] [Related]
18. Respective roles of thyroglobulin, radioiodine imaging, and positron emission tomography in the assessment of thyroid cancer.
Lind P; Kohlfürst S
Semin Nucl Med; 2006 Jul; 36(3):194-205. PubMed ID: 16762610
[TBL] [Abstract][Full Text] [Related]
19. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of dosimetry of radioiodine therapy in benign and malignant thyroid disorders by means of iodine-124 and PET.
Eschmann SM; Reischl G; Bilger K; Kupferschläger J; Thelen MH; Dohmen BM; Besenfelder H; Bares R
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):760-7. PubMed ID: 12029549
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
